DLL3/CD3 bispecific antibody: mechanism of action
1:16
DLL3/CD3 bispecific antibody: mechanism of action
4.2K viewsApr 3, 2020
YouTubeOncology
DLL3-CD3双特异性抗体作用机制
1:16
DLL3-CD3双特异性抗体作用机制
439 viewsJun 13, 2023
bilibili集你肽美呀
DLL3-Driven Innovation in Small Cell Lung Cancer: How Do Experts Apply Pivotal Advances to Practice?
1:14
DLL3-Driven Innovation in Small Cell Lung Cancer: How Do Expert…
38 views8 months ago
YouTubePhysicians' Education Resource
Phase 1 trial of DLL3/CD3 IgG-Like T-Cell Engager BI 764532 in Patients with DLL3 Positive Tumors: Patients with LCNEC | OncLive
Phase 1 trial of DLL3/CD3 IgG-Like T-Cell Engager BI 764532 in Patie…
9 months ago
onclive.com
The Role of DLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer
1:29:31
The Role of DLL3-Targeting Bispecific T-Cell Engagers for Sm…
572 views10 months ago
YouTubeResearch To Practice
Mar 7, 2024: Dr. Aman Chauhan discusses the DAREON™- 5: DLL-3 BiTE for Neuroendocrine Cancers
8:01
Mar 7, 2024: Dr. Aman Chauhan discusses the DAREON™- 5: DLL …
780 viewsMar 7, 2024
YouTubeNeuroendocrine Cancer Foundation
Tarlatamab: Mechanism of Action and Clinical Success in Small Cell Lung Cancer │ Pharmacology
4:26
Tarlatamab: Mechanism of Action and Clinical Success in Small Cell …
3K viewsJun 2, 2024
YouTubePharmacology Insights
1:01
BI 764532: a novel T-cell engager for patients with DLL3+ SCLC and NEC
484 viewsJun 23, 2023
YouTubeVJOncology
1:13
DLL3：肺癌“网红”靶点，或成精准治疗新希望
168 viewsSep 1, 2023
zhihu.com小酷-华美生物
3:40
The role of DLL3-directed agents in treating SCLC
513 viewsMar 18, 2024
YouTubeVJOncology
55:58
New SCLC Therapies: DLL3, Tarlatamab, and Antibody-Drug C…
483 views9 months ago
YouTubeLiveLung
ASCO® 2025 Insights: Alveltamig (ZG006), a DLL3/DLL3/CD3 Trispe…
41 views9 months ago
vumedi.com
0:53
Tarlatamab May Offer Hope for ES-SCLC With Intracranial Metastases
163 views5 months ago
YouTubeCancerNetwork
0:44
Assessing DLL3 as a biomarker for SCLC immunotherapy
76 views9 months ago
YouTubeVJOncology
6:05
Find in video from 04:40CD3 Proteins and Their Function
T Cell Receptor(TCR) and CD3 (FL-Immuno/28)
248.3K viewsMay 10, 2017
YouTubeFrank Lectures
0:59
Bispecific T-Cell Engager (BiTE) Therapy
6.8K viewsFeb 29, 2024
YouTubeWeill Cornell Myeloma Center
45:33
What Makes a Stem Cell a Stem Cell and How Does it Go Bad?
5.4K viewsNov 26, 2024
YouTubeUniversity of California Television (UCTV)
6:55
유도 미사일 항암 기술
1 views1 month ago
YouTubeDavid Lauren Research | Oncology in 3 minutes.
18:16
DeLLphi-301 - FDA Approval of Tarlatamab in Patients w/ Prev Tre…
4.5K viewsOct 22, 2024
YouTubeOncBrothers: Practice-Changing Cancer Discus…
34:43
Engineering Immune Synapses: the potential of T Cell Engagers in can…
180 views3 months ago
YouTubeDassault Systèmes
7:48
Glofitamab, a CD20/CD3 bispecific antibody, in the treatment of R/R D…
1K viewsJun 12, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
The Lens - Patent and Scholarly Search and Analysis
Feb 28, 2013
lens.org
4:06
Imdelltra: New FDA-Approved Treatment for Extensive-Stage Sm…
789 viewsAug 10, 2024
YouTubeAstroByte
8:22
[탈라타맙] SCLC 2차 치료 생존율 분석: 10mg 최적 용량 산출 및 뇌전이 효과(…
3 views1 month ago
YouTubeDavid Lauren Research | Oncology in 3 minutes.
55:52
Episode 48 - NEN Treatments: Focus On DLL3
197 views5 months ago
YouTubeNeuroendocrine Cancer Foundation
14:15
Tarlatamab in DLL3-Expressing Tumors Including NEN • ClinicalTr…
183 views3 months ago
YouTubeNeuroendocrine Cancer Foundation
0:25
DLL III: The Promising New Target for Neuroendocrine Cancer!
2 months ago
YouTubei3 Health
0:53
Unlock New Cancer Treatments: DLL III Testing & Trials Explained
63 views2 months ago
YouTubei3 Health
7:31
肿瘤免疫治疗原理简介
Aug 4, 2020
sohu小狐狸353710451
2:24
The DLL3-targeting BiTE, tarlatamab, for the treatment of SC…
1.4K viewsAug 9, 2022
YouTubeVJOncology
See more videos
Static thumbnail place holder